Gyomor- és nyelőcsőrák: vizsgálatok itt: Kína
724 trials · From ClinicalTrials.gov, checked 2026. november 19.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleA Study of AK104/Placebo Plus AK109/Placebo And Paclitaxel in Gastric or Gastroesophageal Junction Adenocarcinoma
- Where
- Beijing
- Életkor
- 18 év to 75 év
- People
- 506
- Run by
- Akeso
See details and how to joinNCT06341335 - 2. fázisTaking peopleA Study of Sintilimab Combined With Chemotherapy for Neoadjuvant Treatment of Esophageal Squamous Cell Carcinoma
- Where
- Fuzhou
- Életkor
- 18 év to 75 év
- People
- 30
- Run by
- Fujian Cancer Hospital
See details and how to joinNCT06463834 - No phaseNot yet taking people in KínaA Real-World Study of Neoadjuvant/Conversion Therapy for Locally Advanced or Metastatic Gastric Cancer
- Where
- Wuhan
- Életkor
- 18 év to 75 év
- People
- 70
- Run by
- Wuhan University
See details and how to joinNCT06464601 - 2. fázisTaking peopleRadiotherapy in Patients With Metastatic Esophageal Cancer Responding to PD-1 Inhibitor Plus Chemotherapy
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 120
- Run by
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
See details and how to joinNCT06084897 - 2. fázisNot yet taking people in KínaConversion Therapy of Sintilimab in Combination With Fruquintinib and Chemotherapy Versus Sintilimab and Chemotherpay in Stage IV Gastric Cancer
- Where
- Tianjin
- Életkor
- 18 év to 70 év
- People
- 158
- Run by
- Tianjin Medical University Cancer Institute and Hospital
See details and how to joinNCT06454435 - 2. fázisTaking peopleNeoadjuvant Immunotherapy Plus Chemotherapy in Borrmann Type 4 and Large Type 3 Gastric Cancer
- Where
- Guangzhou
- Életkor
- 18 év to 75 év
- People
- 53
- Run by
- Sun Yat-sen University
See details and how to joinNCT06451211 - No phaseTaking peoplePredicting Gastric Cancer Response to Chemo With Multimodal AI Model
- Where
- Guangzhou
- Életkor
- 20 év to 90 év
- People
- 500
- Run by
- Sixth Affiliated Hospital, Sun Yat-sen University
See details and how to joinNCT06451393 - 2. fázisTaking peopleToripalimab Plus FLOT in Locally Advanced Gastric Cancer
- Where
- Zhengzhou
- Életkor
- 18 év to 70 év
- People
- 60
- Run by
- Henan Cancer Hospital
See details and how to joinNCT04891016 - 2. fázisTaking peopleA Study of Paclitaxel Combined With Apatinib and Adebrelimab in Gastric/Gastroesophageal Junction Adenocarcinoma
- Where
- Fuzhou
- Életkor
- 18 év to 75 év
- People
- 30
- Run by
- The First Affiliated Hospital of Xiamen University
See details and how to joinNCT06415669 - 2. fázisTaking peopleNimotuzumab Concurrent With Chemoradiotherapy for Esophageal Cancer Patients
- Where
- Beijing
- Életkor
- 18 év to 80 év
- People
- 55
- Run by
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
See details and how to joinNCT06429839 - No phaseTaking peoplea Single-arm, Single-center, Open Clinical Study
- Where
- Zhengzhou
- Életkor
- 18 év to 75 év
- People
- 10
- Run by
- Beijing Geekgene Technology Co., LTD
See details and how to joinNCT06431100 - No phaseTaking peopleShort-course Hypofractionated Radiotherapy in Combination With Raltitrexed and Tislelizumab
- Where
- Hefei
- Életkor
- 18 év and over
- People
- 25
- Run by
- Anhui Provincial Hospital
See details and how to joinNCT06408584 - No phaseNot yet taking people in KínaEvaluation of the Efficacy and Safety of Indocyanine Green Tracing in 3D Fluorescent Laparoscopic Lymph Node Dissection for Gastric Cancer
- Where
- Jinan
- Életkor
- 18 év to 75 év
- People
- 484
- Run by
- Qilu Hospital of Shandong University
See details and how to joinNCT06421220 - 4. fázisTaking peopleDeeper Intubation Make Effects on Cervical Esophageal ESD
- Where
- Fuzhou
- Életkor
- 18 év to 80 év
- People
- 40
- Run by
- Fujian Provincial Hospital
See details and how to joinNCT06420258 - No phaseTaking peopleDual-Port Laparoscopic Distal Gastrectomy for Gastric Cancer
- Where
- Guangzhou
- Életkor
- 18 év to 75 év
- People
- 300
- Run by
- Nanfang Hospital, Southern Medical University
See details and how to joinNCT05494086 - 2. fázisTaking peopleNimotuzumab Concurrent With Chemoradiotherapy for Patients With Unresectable Esophageal Squamous Cell Carcinoma
- Where
- Beijing
- Életkor
- 18 év to 80 év
- People
- 53
- Run by
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
See details and how to joinNCT06410651 - 2. fázisTaking peoplePhase 2 Trial of KN026+KN046±XELOX in HER2-positive Locally Advanced GC
- Where
- Beijing
- Életkor
- 18 év to 75 év
- People
- 18
- Run by
- Peking University
See details and how to joinNCT06023758 - 3. fázisTaking peopleLocal Therapy for Oligometastatic ESCC Patients Treated With PD-1 Inhibitor
- Where
- Shanghai
- Életkor
- 18 év and over
- People
- 354
- Run by
- Fudan University
See details and how to joinNCT06190782 - 2/3. fázisTaking peopleTislelizumab Combined With Apatinib and Oxaliplatin Plus S1 Vs Oxaliplatin Plus S1 as Neoadjuvant Therapy for Borrmann IV、Large Borrmann III Type and Bulky N Positive Advanced Gastric Cancer
- Where
- Fuzhou
- Életkor
- 18 év to 75 év
- People
- 130
- Run by
- Fujian Cancer Hospital
See details and how to joinNCT05699655 - No phaseTaking peopleMulticenter Cohort Study of ESD and Chemo-radiotherapy for High-risk Early-stage Esophageal Cancer
- Where
- Hangzhou
- Életkor
- 18 év to 75 év
- People
- 120
- Run by
- Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT06385717 - 2. fázisNot yet taking people in KínaTislelizumab Combined With Neoadjuvant Chemotherapy Used in the Perioperative Treatment.
- Where
- Hangzhou
- Életkor
- 18 év to 75 év
- People
- 134
- Run by
- Xiangdong Cheng
See details and how to joinNCT06374901 - 2. fázisTaking peopleNeo-Sequence 2:NCT Plus Anti-angiogenesis Therapy and Immunotherapy for LADGC
- Where
- Beijing
- Életkor
- 18 év to 75 év
- People
- 67
- Run by
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
See details and how to joinNCT06371586 - 2. fázisTaking peopleSerplulimab Combined With Concurrent Chemoradiotherapy for Locally Advanced Treatment Esophageal Cancer in Old Age
- Where
- Nanjing
- Életkor
- 75 év and over
- People
- 50
- Run by
- The First Affiliated Hospital with Nanjing Medical University
See details and how to joinNCT06354218 - 2/3. fázisTaking peopleA Study of Neoadjuvant Therapy for the Treatment of Patients With Locally Advanced Esophageal Squamous Cell Carcinoma
- Where
- Chongqing
- Életkor
- 18 év to 80 év
- People
- 266
- Run by
- Army Medical Center of PLA
See details and how to joinNCT06354530 - 2/3. fázisTaking peopleDV Combined With Cadonilimab in Subjects With HER2-expressing Gastric Cancer and Gastroesophageal Junction Adenocarcinoma After Progression on First-line Therapy
- Where
- Beijing, Changsha, Chengdu, Harbin, Jinan, Kunming, Qingdao, Shanghai, Wuhan, Xiamen, Xuzhou, Zhengzhou
- Életkor
- 18 év to 75 év
- People
- 90
- Run by
- RemeGen Co., Ltd.
See details and how to joinNCT06221748